BlackRock’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $293M | Sell |
|
|||||
|
2025
Q2 | $475M | Buy |
|
|||||
|
2025
Q1 | $404M | Buy |
|
|||||
|
2024
Q4 | $481M | Sell |
|
|||||
|
2024
Q3 | $500M | Buy |
|
|||||
|
2024
Q2 | $493M | Sell |
|
|||||
|
2024
Q1 | $511M | Sell |
|
|||||
|
2023
Q4 | $516M | Buy |
|
|||||
|
2023
Q3 | $518M | Sell |
|
|||||
|
2023
Q2 | $495M | Buy |
|
|||||
|
2023
Q1 | $478M | Sell |
|
|||||
|
2022
Q4 | $462M | Buy |
|
|||||
|
2022
Q3 | $410M | Sell |
|
|||||
|
2022
Q2 | $364M | Sell |
|
|||||
|
2022
Q1 | $376M | Sell |
|
|||||
|
2021
Q4 | $355M | Sell |
|
|||||
|
2021
Q3 | $493M | Buy |
|
|||||
|
2021
Q2 | $398M | Buy |
|
|||||
|
2021
Q1 | $533M | Buy |
|
|||||
|
2020
Q4 | $558M | Sell |
|
|||||
|
2020
Q3 | $427M | Sell |
|
|||||
|
2020
Q2 | $456M | Sell |
|
|||||
|
2020
Q1 | $595M | Buy |
|
|||||
|
2019
Q4 | $679M | Buy |
|
|||||
|
2019
Q3 | $740M | Sell |
|
|||||
|
2019
Q2 | $722M | Sell |
|
|||||
|
2019
Q1 | $559M | Buy |
|
|||||
|
2018
Q4 | $603M | Buy |
|
|||||
|
2018
Q3 | $680M | Sell |
|
|||||
|
2018
Q2 | $539M | Sell |
|
|||||
|
2018
Q1 | $507M | Buy |
|
|||||
|
2017
Q4 | $387M | Buy |
|
|||||
|
2017
Q3 | $289M | Buy |
|
|||||
|
2017
Q2 | $247M | Sell |
|
|||||
|
2017
Q1 | $255M | Buy |
|
|||||
|
2016
Q4 | $517K | Sell |
|
|||||
|
2016
Q3 | $507K | Buy |
|
|||||
|
2016
Q2 | $385K | Buy |
|
|||||
|
2016
Q1 | $122K | Buy |
|
|||||
|
2015
Q4 | $50K | Buy |
|
|||||
|
2015
Q3 | $37K | Sell |
|
|||||
|
2015
Q2 | $193K | Sell |
|
|||||
|
2015
Q1 | $242K | Sell |
|
|||||
|
2014
Q4 | $217K | Buy |
|
|||||
|
2014
Q3 | $193K | Sell |
|
|||||
|
2014
Q2 | $567K | Buy |
|
|||||
|
2014
Q1 | $195K | Buy |
|
|||||
|
2013
Q4 | $70K | Sell |
|
|||||
|
2013
Q3 | $68K | Buy |
|
|||||
|
2013
Q2 | $69K | Buy |
|